Navigation Links
New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting
Date:1/25/2010

A new, in-home training device with virtual reality cues improving gait and balance in patients with Parkinson's disease was presented by lead researcher Dr. Alberto Espay at the American Acadamy of Neurology annual meeting.

(PRWEB) January 25, 2010 -- Quality of life and motor function are impaired by shuffling and freezing of gait in people with Parkinson's disease (PD).

It is well known that certain auditory and visual cues can improve motor function in people with PD.

Dr. Alberto Espay, presented the results of his study which showed successful treatment of gait impairment for Parkinson's disease by using a new patented device, the GaitAid.

Patients in the study received the device for in-home use during a two week period. The participants used the device daily for 20 minutes. Gait parameters were measured before, during and after the two week period.

Over 70% of patients in this study improved their gait.

Dr. Espay concluded his presentation: "Gait velocity and stride length were improved in PD patients with a marked residual (lasting) effect.".

During his platform presentation, Dr. Espay acknowleged this device as a "desirable, non-pharmacologic, intervention to improve walking in PD.", noting that the device is low cost, easy to use (no training by professionals is needed to use the device at home ) and it provides improved functioning by the patient during and after use.

The devices used in this study are registered with the FDA as the GaitAid device and are available for a one month trial period to individuals, clinicians, and retirement homes at the company's website: www.medigait.com

More information about the GaitAid device as well as clinical trials is available on MediGait's website.

About Dr. Espay:
Dr. Alberto Espay completed his Neurology training at Indiana University, where he was awarded the Alexander Treloar Ross Award Honorable Mention for the most outstanding paper by a neurology resident. He trained in Movement Disorders at the Toronto Western Hospital, with Dr. Anthony Lang, during 2001-2003. He then completed a Dystonia Medical Research Foundation Clinical Research Fellowship with special training in Electrophysiology of Movement Disorders, with Dr. Robert Chen, and a thesis-based MSc Graduate program in Clinical Epidemiology and Health Care Research at the University of Toronto, both during 2003-2005. Dr. Espay received a two-year Sam and Fran Belzberg and Dennis and Barbara Kessler DMRF award for his study “Pathophysiology of Psychogenic Dystonia,” published by the Annals of Neurology in 2006. He has published 27 peer-reviewed articles and has authored 6 book chapters and 24 published abstracts and presented papers.  Dr. Espay has been awarded the Dean’s Scholar in Clinical Research Award by the University of Cincinnati for the years 06/07, 07/08, and 08/09 which “fosters the career development of promising junior faculty in clinical research.” Dr. Espay is the principal investigator in four ongoing investigator-initiated clinical studies at the University of Cincinnati, including a clinical trial sponsored by the Michael J. Fox Foundation, evaluating the effects of methylphenidate on the freezing of gait in patients with Parkinson’s disease. He serves as a member of the Institutional Research Board at the University of Cincinnati and is an ad hoc reviewer for 13 neurology and medical journals. Dr. Espay is the founder and director of the Toronto Western Extended Research Network, a community of movement disorders neurologists designing and developing common clinical research protocols. He has been an Assistant Professor of Neurology at the University of Cincinnati since July 2005.

About the GaitAid and MediGait:
The idea for the GaitAid project was sparked 12 years ago while Professor Baram was designing a mechanism for NASA to navigate low-flying helicopters around obstacles. The concept of the design, which Baram later applied to the medical device, is that the optical images of objects help the observer navigate, stabilize and pace movement in space.

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3513564.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment for Parkinson's Disease Gait Presented at the American Acadamy of Neurology Annual Meeting
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews ... and other Butler products. Ken was impressed with the safety and reliability of ... the product on his show. This endorsement by Ken Matthews can be heard ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new directory ... contact points to easily connect elderly veterans of America's armed forces to a ... It also conveys material on this year's increase in the Veterans Pension with ...
(Date:2/17/2017)... ... 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, a ... non-controlled substances plus the ability to manage orders on their desktop or mobile ... electronic prescriptions, according to the Office of the National Coordinator of Health IT, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive Action ... Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd ... preventive action (PA)? , The methods share techniques and tools but they are ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP Revenue Cycle Solutions (MAP ... has been promoted to Chief Executive Officer. , The need for maximizing ... shift that demands the transition from pay-for-service to pay-for-performance models. By delivering efficient ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: PRGO) today ... and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral ... Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 ... relief of cough in adults and children 6 years of ... January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... 17, 2017   FormFast , the leader in ... partnership with Engage , one of the largest ... . FormFast will serve as the forms automation and ... MEDITECH .  FormFast is a ... complement and enhance the electronic health record. FormFast,s technology ...
(Date:2/16/2017)... Pa. , Feb. 16, 2017 Absorption ... biologics, and medical devices, is pleased to announce that ... has been selected as a winner of the 2017 ... SmartCEO Magazine and recognizes driven executives for their ... work ethic. The awards ceremony and celebration is on ...
Breaking Medicine Technology: